About Danita Sanborn, MD

Dr. Danita Sanborn is a clinical cardiologist and a specialist in Echocardiography. She also serves as the Medical Director of the Paul Dudley White Associates Cardiology Fellows' Practice.

Dr. Sanborn received her MD degree from the University of Iowa College of Medicine. She completed residency training in Internal Medicine and fellowship training in Cardiovascular Disease with an advanced fellowship in Echocardiography at Massachusetts General Hospital. She then joined the faculty in the Cardiology Division at MGH and Harvard Medical School. During her fellowship, she also completed Harvard Medical School's Scholars in Clinical Science Program and earned a Masters of Medical Science Degree from HMS.  She holds board certifications in Cardiovascular Disease from the ABIM as well as Comprehensive Certification in Echocardiography from the NBE. She is a fellow of both the American College of Cardiology and the American Society of Echocardiography.

Her clinical interests include general clinical cardiology, valve disease, cardiomyopathy, structural heart disease and echocardiography.  Her research interests include refining the role of echocardiography as a tool to better understand uncommon cardiomyopathies including Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Hypertrophic Cardiomyopathy.  She managed the Echo Core Lab for the Multidisciplinary Study of ARVC and participated with a group of experts who proposed Modifications of the original Task Force Criteria for the diagnosis of ARVC.  She holds the administrative and teaching role in MGH's Cardiology Fellowship as the Associate Fellowship Program Director and Medical Director of the Paul Dudley White Associates and serves as the Director of Urgent Care for the Cardiology Division

Clinical Interests:

Treats:

Locations

Cardiology Paul Dudley White Associates
55 Fruit Street
Boston, MA 02114-2696
617-726-1543
Fax: 617-643-1639

Echocardiography
55 Fruit Street
Boston, MA 02114-2696
617-726-1543
Fax: 617-643-1639

Medical Education

  • MD, University of Iowa College of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Cardiovascular Disease, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Sanborn's research interests include defining and refining the role of echocardiography as a tool to better understand uncommon cardiomyopathies including Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Hypertrophic Cardiomyopathy. She managed the Echo Core Lab for the North American Multidisciplinary Study of ARVC and participated with a group of experts who proposed Modifications of the original Task Force Criteria for the diagnosis of ARVC, published in 2010. She has also used her expertise in echocardiography to collaborate with colleagues at MGH to study echocardiographic predictors of atrial fibrillation in cryptogenic stroke and the genetic basis of cardiovascular diseases including atrial fibrillation and cardiomyopathy.

Publications

  • View my most recent publications at PubMed

    Select Publications:

    1. Neilan TG, et al. Engl J Med. 2018 Oct 25;379(17):1658-1669. 
    2. Te Riele ASJM, et al .JACC Cardiovasc Imaging. 2015 May;8(5):597-611
    3. Rothman RD,et al.  .Am J Cardiol. 2012 Oct 15;110(8):1169-74.
    4. Yoerger, DM, Marcus, F, et al, Echocardiographic Findings in Patients Meeting Task Force Criteria for ARVD; JACC, 2005; 45: 860-65.

    5. Yoerger DM, et al. Time Course of Pressure Gradient Response After First Alcohol Septal Ablation for HOCM. Am J Cardiol, 2006; 97:1511-14
    6. Marcus FI, McKenna WJ, et al. Diagnosis of ARVC/D; Proposed modification of the Task Force Criteria. Circulation 2010
    7. Chen AA et al. Acute predictors of subacute complete heart block after alcohol septal ablation for HOCM. Am J Cardiol. 2006 Jan 15;97(2):264-9
    8. Jassal DS, Neilan TG et al.  Sustained Improvement in LV Diastolic Function after Alcohol Septal Ablation for HOCM. Eur Heart J. 2006 Aug;27(15):1805-10.